U.S. Endomyocardial Biopsy Market Size & Outlook, 2025-2030
Related Markets
U.S. endomyocardial biopsy market highlights
- The U.S. endomyocardial biopsy market generated a revenue of USD 123.7 million in 2024 and is expected to reach USD 159.4 million by 2030.
- The U.S. market is expected to grow at a CAGR of 4.3% from 2025 to 2030.
- In terms of segment, forceps was the largest revenue generating product in 2024.
- Forceps is the most lucrative product segment registering the fastest growth during the forecast period.
Endomyocardial biopsy market data book summary
| Market revenue in 2024 | USD 123.7 million |
| Market revenue in 2030 | USD 159.4 million |
| Growth rate | 4.3% (CAGR from 2025 to 2030) |
| Largest segment | Forceps |
| Fastest growing segment | Forceps |
| Historical data | 2018 - 2023 |
| Base year | 2024 |
| Forecast period | 2025 - 2030 |
| Quantitative units | Revenue in USD million |
| Market segmentation | Forceps, Accessories |
| Key market players worldwide | Argon Medical Devices, Terumo Corp, Cardinal Health Inc, Scholten Surgical Instruments, Changzhou Lookmed Medical Instrument Co., Fehling Instruments |
Other key industry trends
- In terms of revenue, U.S. accounted for 33.9% of the global endomyocardial biopsy market in 2024.
- Country-wise, U.S. is expected to lead the global market in terms of revenue in 2030.
- In North America, U.S. endomyocardial biopsy market is projected to lead the regional market in terms of revenue in 2030.
- Canada is the fastest growing regional market in North America and is projected to reach USD 49.5 million by 2030.
No credit card required*
Horizon in a snapshot
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
Endomyocardial Biopsy Market Scope
Endomyocardial Biopsy Market Companies
| Name | Profile | # Employees | HQ | Website |
|---|---|---|---|---|
| Fehling Instruments | View profile | 11-50 | Karlstein, Bayern, Germany, Europe | https://www.fehling-instruments.de |
| Changzhou Lookmed Medical Instrument Co. | View profile | 51-100 | Changzhou, Zhejiang, China, Asia | http://www.lookmedchina.com |
| Scholten Surgical Instruments | View profile | 1-10 | Lodi, California, United States, North America | https://www.novatome.com |
| Argon Medical Devices | View profile | 1001-5000 | Plano, Texas, United States, North America | http://www.argonmedical.com/ |
| Cardinal Health Inc | View profile | 48000 | 7000 Cardinal Place, Dublin, OH, United States, 43017 | https://www.cardinalhealth.com |
| Terumo Corp | View profile | 30207 | 2-44-1 Hatagaya, Shibuya-ku, Tokyo, Japan, 151-0072 | https://www.terumo.com |
U.S. endomyocardial biopsy market outlook
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to endomyocardial biopsy market will help companies and investors design strategic landscapes.
Forceps was the largest segment with a revenue share of 76.07% in 2024. Horizon Databook has segmented the U.S. endomyocardial biopsy market based on forceps, accessories covering the revenue growth of each sub-segment from 2018 to 2030.
The U.S. has the largest endomyocardial biopsy market and its growth can be attributed to factors such as the presence of well-established healthcare infrastructure, high healthcare spending, and increasing demand for minimally invasive diagnostic procedures.
The increasing rate of heart transplants in the U.S. has further contributed to the country’s market growth. According to data published by the United Network for Organ Sharing, in 2022, over 4,111 heart transplants were performed in the U.S.
Endomyocardial biopsy remains a valuable diagnostic tool for assessing graft function & detecting rejection in heart transplant patients, and it is likely to continue to be used as part of routine post-transplant.
Reasons to subscribe to U.S. endomyocardial biopsy market databook:
-
Access to comprehensive data: Horizon Databook provides over 1 million market statistics and 20,000+ reports, offering extensive coverage across various industries and regions.
-
Informed decision making: Subscribers gain insights into market trends, customer preferences, and competitor strategies, empowering informed business decisions.
-
Cost-Effective solution: It's recognized as the world's most cost-effective market research database, offering high ROI through its vast repository of data and reports.
-
Customizable reports: Tailored reports and analytics allow companies to drill down into specific markets, demographics, or product segments, adapting to unique business needs.
-
Strategic advantage: By staying updated with the latest market intelligence, companies can stay ahead of competitors, anticipate industry shifts, and capitalize on emerging opportunities.
Target buyers of U.S. endomyocardial biopsy market databook
-
Our clientele includes a mix of endomyocardial biopsy market companies, investment firms, advisory firms & academic institutions.
-
30% of our revenue is generated working with investment firms and helping them identify viable opportunity areas.
-
Approximately 65% of our revenue is generated working with competitive intelligence & market intelligence teams of market participants (manufacturers, service providers, etc.).
-
The rest of the revenue is generated working with academic and research not-for-profit institutes. We do our bit of pro-bono by working with these institutions at subsidized rates.
Horizon Databook provides a detailed overview of country-level data and insights on the U.S. endomyocardial biopsy market , including forecasts for subscribers. This country databook contains high-level insights into U.S. endomyocardial biopsy market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
Partial client list
U.S. endomyocardial biopsy market size, by product, 2018-2030 (US$M)
U.S. Endomyocardial Biopsy Market Outlook Share, 2024 & 2030 (US$M)
Related industry reports
Related statistics
Sign up - it's easy, and free!
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
